NCT04096547View on ClinicalTrials.gov

Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment

UnknownOBSERVATIONAL

Enrollment

1,200

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

February 28, 2022

Study Completion Date

August 30, 2022

Conditions

Atrial FibrillationRivaroxabanElderlyRenal Insufficiency

Interventions

DRUG

Rivaroxaban

rivaroxaban for stroke prevention of atrial fibrillation

Trial Locations (1)

135-710

RECRUITING

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

Samsung Medical Center

OTHER